Literature DB >> 12182454

Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay.

Stephanie Mayer1, Monika Laumer, Andreas Mackensen, Reinhard Andreesen, Stefan W Krause.   

Abstract

Tetanus toxoid (TT) is an antigen known to induce strong T cell specific immune responses in humans after vaccination. Here we have used the Elispot assay to assess the number of TT-specific Interferon-gamma (IFN-gamma) secreting T cells present in individuals and monitored the number of TT specific T cells present in the donors for more than two years. In each of the 22 healthy volunteers tested, TT-specific T cells could be detected. Six out of 7 repetitively tested donors showed a remarkably constant number of TT-specific IFN-gamma secreting T cells over several months, whereas one donor demonstrated a transient increase during a flu-like infection. Three healthy donors received TT booster-immunizations and showed significant increases in the number of TT-specific IFN-gamma secreting T cells which reached peak levels by 4 weeks after vaccination. Depletion of either CD4+ T cells, CD8+ T cells or CD16+/CD56+ T cells by immunomagnetic separation demonstrated that TT-specific IFN-gamma secretion is mediated exclusively by CD4+ T cells. In addition, HLA class-I and -II blocking studies showed that IFN-gamma production is performed by HLA class-II restricted cells. Our data show that the Elispot assay can be reliably used to assess the number of TT-specific CD4+ IFN-gamma producing cells (i.e. probably T helper cells) and therefore maybe also useful for the assessment of reactions to other helper antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182454     DOI: 10.1078/0171-2985-00131

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

1.  Submicroscopic Plasmodium infection during pregnancy is associated with reduced antibody levels to tetanus toxoid.

Authors:  C Álvarez-Larrotta; O M Agudelo; Y Duque; K Gavina; S K Yanow; A Maestre; J Carmona-Fonseca; E Arango
Journal:  Clin Exp Immunol       Date:  2018-10-19       Impact factor: 4.330

2.  Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus.

Authors:  Matthieu Perreau; Eric J Kremer
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Authors:  Mohamed Hashem; Hanaa El-Karaksy; Mohamed T Shata; Maha Sobhy; Heba Helmy; Suzan El-Naghi; Gehan Galal; Zainab Z Ali; Gamal Esmat; Sayed F Abdelwahab; G Thomas Strickland; Samer S El-Kamary
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

Review 4.  Sensitization and tolerization to brain antigens in stroke.

Authors:  K J Becker
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

5.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Authors:  Laurel Yong-Hwa Lee; Do Lien Anh Ha; Cameron Simmons; Menno D de Jong; Nguyen Van Vinh Chau; Reto Schumacher; Yan Chun Peng; Andrew J McMichael; Jeremy J Farrar; Geoffrey L Smith; Alain R M Townsend; Brigitte A Askonas; Sarah Rowland-Jones; Tao Dong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  The fight-or-flight response is associated with PBMC expression profiles related to immune defence and recovery in swine.

Authors:  Michael Oster; Mathias Scheel; Eduard Muráni; Siriluck Ponsuksili; Manuela Zebunke; Birger Puppe; Klaus Wimmers
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease.

Authors:  Fauziyya Muhammad; Dawei Wang; Alyssa Montieth; Stacey Lee; Janine Preble; C Stephen Foster; Theresa A Larson; Kai Ding; Justin D Dvorak; Darren J Lee
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

Review 8.  Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.

Authors:  Majed Ghattas; Garima Dwivedi; Marc Lavertu; Mohamad-Gabriel Alameh
Journal:  Vaccines (Basel)       Date:  2021-12-16

9.  Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells.

Authors:  Eleonora Li Causi; Suraj C Parikh; Lindsey Chudley; David M Layfield; Christian H Ottensmeier; Freda K Stevenson; Gianfranco Di Genova
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

10.  An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.

Authors:  Julie D McIntosh; Kristy Manning; Shilpa Chokshi; Nikolai V Naoumov; John D Fraser; P Rod Dunbar; John A Taylor
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.